Obesity Featured Articles

  1. Building Recruitment Into Early-Phase Trial Design 7/30/2026

    Successful recruitment starts with smart study design. Early recruitment insight improves feasibility, supports realistic timelines, and reduces enrollment risk.

  2. A Sponsor's Guide To Evaluating CRO Data Governance 7/30/2026

    Evaluate CRO data governance with a risk-based framework that strengthens data quality, traceability, compliance, and regulatory readiness.

  3. Why Driving Impairment Evaluation Is Becoming More Important In CNS Drug Development 7/30/2026

    Vague warning labels leave patients and prescribers guessing about driving safety. Discover recent compliance data and learn how simulation studies clarify real-world functional risk.

  4. Threat From Within: Why Biopharma's Drug Development Bottleneck Is Systemic 7/30/2026

    As FDA timelines and AI-enabled development accelerate, biopharma’s biggest bottleneck may be its own ability to make earlier, cross-functional decisions.

  5. Demonstrating The Value Of Investigational Drug Services Through Time-Based Metrics 7/29/2026

    Learn how adopting time-based metrics helps research teams accurately track workload, optimize staffing, and justify trial budgets.

  6. Beyond Task Tracking: Why ClinOps Needs Dependency Intelligence 7/29/2026

    Clinical trial operations will always need task tracking, but they're not enough on their own. Dependency intelligence shifts the focus toward readiness not reaction.

  7. To Take On Transverse Myelitis, Researchers Must First Address Heterogeneity And Misguided Outcome Measures 7/29/2026

    UNC researcher Irena Dujmovic Basuroski, MD, Ph.D., discusses why transverse myelitis remains difficult to study, how multicenter collaboration and adaptive trial designs may help, and why better clinical, patient-reported, and biomarker-based measures are essential to advancing treatment.

  8. From Signal To Strategy: What Oncology Basket Trials Can Teach Clinical Development Teams 7/29/2026

    AbbVie's Svetlana Kobina discusses how basket trials can help clinical development teams move from early clinical signals to a more disciplined strategy.

  9. What 9 Years Of MDR Experience Is Changing About PMCF Planning 7/28/2026

    Re-evaluate your compliance roadmap by exploring expert perspectives on navigating regulatory shifts, distinguishing core surveillance obligations, and building a defensible, value-driven clinical data strategy.

  10. 4 Hidden Gaps In Clinical Trial Preparation For Small Biotechs 7/28/2026

    Gaps are not always visible at the executive level, but their consequences are very real — affecting timelines, budgets, data quality, and ultimately the likelihood of regulatory success.